Anti-CWH43 monoclonal antibody

Pre-made anti-CWH43 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CWH43/CWH43 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0632-Ab-1/ GM-Tg-hg-IP0632-Ab-2Anti-Human CWH43 monoclonal antibodyHuman
GM-Tg-rg-IP0632-Ab-1/ GM-Tg-rg-IP0632-Ab-2Anti-Rat CWH43 monoclonal antibodyRat
GM-Tg-mg-IP0632-Ab-1/ GM-Tg-mg-IP0632-Ab-2Anti-Mouse CWH43 monoclonal antibodyMouse
GM-Tg-cynog-IP0632-Ab-1/ GM-Tg-cynog-IP0632-Ab-2Anti-Cynomolgus/ Rhesus macaque CWH43 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0632-Ab-1/ GM-Tg-felg-IP0632-Ab-2Anti-Feline CWH43 monoclonal antibodyFeline
GM-Tg-cang-IP0632-Ab-1/ GM-Tg-cang-IP0632-Ab-2Anti-Canine CWH43 monoclonal antibodyCanine
GM-Tg-bovg-IP0632-Ab-1/ GM-Tg-bovg-IP0632-Ab-2Anti-Bovine CWH43 monoclonal antibodyBovine
GM-Tg-equg-IP0632-Ab-1/ GM-Tg-equg-IP0632-Ab-2Anti-Equine CWH43 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0632-Ab-1/ GM-Tg-hg-IP0632-Ab-2; GM-Tg-rg-IP0632-Ab-1/ GM-Tg-rg-IP0632-Ab-2;
GM-Tg-mg-IP0632-Ab-1/ GM-Tg-mg-IP0632-Ab-2; GM-Tg-cynog-IP0632-Ab-1/ GM-Tg-cynog-IP0632-Ab-2;
GM-Tg-felg-IP0632-Ab-1/ GM-Tg-felg-IP0632-Ab-2; GM-Tg-cang-IP0632-Ab-1/ GM-Tg-cang-IP0632-Ab-2;
GM-Tg-bovg-IP0632-Ab-1/ GM-Tg-bovg-IP0632-Ab-2; GM-Tg-equg-IP0632-Ab-1/ GM-Tg-equg-IP0632-Ab-2
Products NameAnti-CWH43 monoclonal antibody
Formatmab
Target NameCWH43
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CWH43 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0632-Ag-1Recombinant multi-species PG2IP/ CWH43/ CWH43-C protein


    Target information

    Target IDGM-IP0632
    Target NameCWH43
    Gene ID80157,231293,305307,706415,482143,101088079,785528,100060814
    Gene Symbol and SynonymsC130090K23Rik,CWH43,CWH43-C,imds-60,PGAP2IP,RGD1310958
    Uniprot AccessionQ9H720
    Uniprot Entry NamePG2IP_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000109182
    Target ClassificationN/A

    The target: CWH43, gene name: CWH43, also named as CWH43-C, PGAP2IP. Predicted to be involved in GPI anchor biosynthetic process. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.